Your browser doesn't support javascript.
loading
Prognostic impact of early tumor shrinkage and depth of response in patients with microsatellite instability-high metastatic colorectal cancer receiving immune checkpoint inhibitors.
Fucà, Giovanni; Corti, Francesca; Ambrosini, Margherita; Intini, Rossana; Salati, Massimiliano; Fenocchio, Elisabetta; Manca, Paolo; Manai, Chiara; Daniel, Francesca; Raimondi, Alessandra; Morano, Federica; Corallo, Salvatore; Prisciandaro, Michele; Spallanzani, Andrea; Quarà, Virginia; Belli, Carmen; Vaiani, Marta; Curigliano, Giuseppe; Cremolini, Chiara; De Braud, Filippo; Di Bartolomeo, Maria; Zagonel, Vittorina; Lonardi, Sara; Pietrantonio, Filippo.
  • Fucà G; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Corti F; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Ambrosini M; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Intini R; Department of Oncology, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy.
  • Salati M; Department of Oncology and Hematology, University Hospital Modena, Modena, Italy.
  • Fenocchio E; Department of Medical Oncology, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy.
  • Manca P; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Manai C; Department of Oncology, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy.
  • Daniel F; Department of Oncology, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy.
  • Raimondi A; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Morano F; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Corallo S; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Prisciandaro M; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Spallanzani A; Department of Oncology and Hematology, University Hospital Modena, Modena, Italy.
  • Quarà V; Department of Medical Oncology, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy.
  • Belli C; Division of Early Drug Development, European Institute of Oncology IRCCS, Milan, Italy.
  • Vaiani M; Radiology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Curigliano G; Division of Early Drug Development, European Institute of Oncology IRCCS, Milan, Italy.
  • Cremolini C; Oncology and Hemato-oncology Department, University of Milan, Milan, Italy.
  • De Braud F; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
  • Di Bartolomeo M; Unit of Medical Oncology 2, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.
  • Zagonel V; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Lonardi S; Oncology and Hemato-oncology Department, University of Milan, Milan, Italy.
  • Pietrantonio F; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
J Immunother Cancer ; 9(4)2021 04.
Article en En | MEDLINE | ID: mdl-33849927

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Carga Tumoral / Inestabilidad de Microsatélites / Inhibidores de Puntos de Control Inmunológico Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male País como asunto: Europa Idioma: En Año: 2021 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Carga Tumoral / Inestabilidad de Microsatélites / Inhibidores de Puntos de Control Inmunológico Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male País como asunto: Europa Idioma: En Año: 2021 Tipo del documento: Article